PRECISION BIOSCIENCES INC

Profile

Company Names

PRECISION BIOSCIENCES INC

Addresses

302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC 27701

Phone Numbers

919-314-5512

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$153,275,013.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2019-03-01 
$39,550,000.00 
$70,000,000.00 
$30,450,000.00 
Debt 
2
2018-05-25 
$88,075,013.00 
$110,000,000.00 
$21,924,987.00 
Equity 
1
2015-04-30 
$25,650,000.00 
$25,650,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ADELMAN 
DIRECTOR
CERIMON PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND, L.P.   |  SIENTRA, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  SOLSTICE BIOLOGICS LLC   |  LABRYS BIOLOGICS, INC.   |  VENBIO SELECT FUND LTD.   |  VENBIO SELECT FUND LLC   |  PRECISION BIOSCIENCES INC   |  METACRINE, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  VENBIO GLOBAL STRATEGIC FUND II L.P.   |  TP THERAPEUTICS, INC.   |  VENBIO GLOBAL STRATEGIC FUND III, L.P.   |  VENBIO GLOBAL STRATEGIC FUND IV, L.P.
ABID 
 
ANSARI 
EXECUTIVE OFFICER
PRECISION BIOSCIENCES INC   |  GENERAL ONCOLOGY, INC.
BEN 
 
AUSPITZ 
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  UNUM THERAPEUTICS, INC.   |  PRECISION BIOSCIENCES INC   |  COMPASS THERAPEUTICS LLC   |  CHECKMATE PHARMACEUTICALS, INC.   |  INDALO THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ZERO POINT FIVE THERAPEUTICS, INC.   |  ANTLIA BIOSCIENCE, INC.
DEREK 
 
JANTZ 
EXECUTIVE OFFICER, DIRECTOR
PRECISION BIOSCIENCES INC   |  TUNE THERAPEUTICS, INC.
MATTHEW 
 
KANE 
EXECUTIVE OFFICER, DIRECTOR
PRECISION BIOSCIENCES INC   |  MJ FREEWAY, LLC   |  GREF IV REIT LLC   |  Z CAPITAL CREDIT TACTICAL FUND, L.P.   |  PIROUETTE MEDICAL INC.   |  AKERNA CORP.   |  PIROUETTE PHARMA INC.
TODD 
 
MELBY 
EXECUTIVE OFFICER
PRECISION BIOSCIENCES INC
SHALINI 
 
SHARP 
DIRECTOR
ANTIGENICS INC /DE/   |  ULTRAGENYX PHARMACEUTICAL INC.   |  AGENUS INC   |  PRECISION BIOSCIENCES INC   |  MAHZI THERAPEUTICS INC.   |  IAMBIC THERAPEUTICS, INC.
JEFF 
 
SMITH 
EXECUTIVE OFFICER
GRATIA PLENA PARTNERS L P   |  GRATIA PLENA SELECT PARTNERS LP   |  SONICMULE INC   |  RIISNET, LLC   |  VERGEPOINTE CAPITAL FUND VII, LP   |  SMULE, INC.   |  FIRESCOPE INC   |  ACCOLADE, INC.   |  PRECISION BIOSCIENCES INC   |  MARMONT, INC.   |  KODIAK BP, LLC   |  SURGICENTER OF SAN ANTONIO AT WESTOVER HILLS, LLC   |  ASSOCIATES EQUITY FUND VI LLC   |  EXECUTIVE SURGERY CENTER, L.L.C.   |  FAITHBOX, INC.   |  FANBOX SUBSCRIPTION SERVICES, INC.   |  IGNITE GROWTH BRANDS INC.   |  -PARAGON VMS USA CORP   |  GENOMONCOLOGY, LLC   |  MEMORIAL CITY PARTNERS, LLC   |  UNITED IN GAMING INC   |  WORLD CHAMPION FANTASY INC.   |  WAHI NUTRITION, INC.   |  SONRAI SECURITY INC.   |  RESTOR METABOLIX INC   |  WHITEHAWK INCOME CORP   |  ARC FUND I, LLC   |  BAMBOO HEALTH HOLDING COMPANY, INC.
TONY 
 
YAO 
DIRECTOR
NEXIMMUNE, INC.   |  PRECISION BIOSCIENCES INC   |  4D MOLECULAR THERAPEUTICS INC   |  ARROWMARK LIFE SCIENCE FUND II OFFSHORE FEEDER, LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-03-15
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2019-03-01 
2018-06-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-25 
2015-05-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#